Annexon

Annexon Enterprise Value

The Enterprise Value (EV) of Annexon (ANNX) as of Oct 12, 2026 is 559.13 M USD. In the previous year, Enterprise Value (EV) was 482.55 M USD — a change of 15.87% (higher).

Enterprise Value

559.13 MUSD

YoY

15.87%

Last updated:

Enterprise Value (EV) of Annexon is 2025 559.13 M USD. Enterprise Value (EV) of Annexon was 2024 482.55 M USD. It decreases by 15.87% higher compared to the previous year.

The Annexon Enterprise Value history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Enterprise Value
Date
Enterprise Value
Jan 1, 2018
750.39 M USD
Jan 1, 2019
750.63 M USD
Jan 1, 2020
443.36 M USD
Jan 1, 2021
551.85 M USD
Jan 1, 2022
551.91 M USD
Jan 1, 2023
534.85 M USD
Jan 1, 2024
482.55 M USD
Jan 1, 2025
559.13 M USD
The Annexon Enterprise Value history
YEAREnterprise ValueYoY
559.13 MUSD+15.87%
482.55 MUSD-9.78%
534.85 MUSD-3.09%
551.91 MUSD+0.01%
551.85 MUSD+24.47%
443.36 MUSD-40.94%
750.63 MUSD+0.03%
750.39 MUSD-5.21%
791.60 MUSD—
Access this data via the Eulerpool API

Annexon Stock analysis

What does Annexon do? Annexon Inc is a biopharmaceutical company based in South San Francisco, California. It was founded in 2011 by Doug Love, Ted Love, and Arnon Rosenthal, who had previously worked at major pharmaceutical companies such as Genentech and Novartis. The company's main goal is to develop new treatment options for neurodegenerative diseases, focusing on the development of drugs that target the autophagy process in cells to reduce damage to nerve cells and alleviate symptoms. Annexon Inc has two divisions, Annexon Biosciences and Annexon Clinical, with partnerships with renowned pharmaceutical companies to advance drug development. Its main product is ANX005, a therapeutic antibody protein that targets the role of the complement system in neurodegenerative diseases. Annexon Inc has received multiple awards for its work and innovations and has a dedicated team of scientists and executives committed to improving the lives of people with neurodegenerative diseases. Annexon is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Annexon stock

Enterprise Value (EV) of Annexon is 559.13 M USD in 2025.

Enterprise Value (EV) of Annexon changed from 482.55 M USD to 559.13 M USD, representing a 15.87% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Enterprise Value (EV) Annexon since 2006 – with annual values, charts, and detailed analysis.

Enterprise Value represents the total value of a company, including both equity and debt, minus cash. It provides a more comprehensive picture than market capitalization alone.

EV = Market Capitalization + Total Debt - Cash & Equivalents

To evaluate Enterprise Value (EV)'s USD, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Enterprise Value (EV).

A 'good' USD varies by industry and company stage. On Eulerpool, you can compare Enterprise Value (EV)'s Annexon with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Annexon

All Key Metrics — Annexon